Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

被引:79
作者
Halberstadt, Adam L. [1 ]
Geyer, Mark A. [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA
关键词
Psychedelic; 5-HT2A; Head twitch; LSD; SEROTONIN 2A RECEPTOR; 5-HYDROXYTRYPTAMINE (5-HT)(2A); HIGH-AFFINITY; 5-HT2A; AGONIST; PHENETHYLAMINE; ANTAGONIST; MODULATION; ACTIVATION; BEHAVIOR;
D O I
10.1016/j.neuropharm.2013.08.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
N-benzyl substitution markedly enhances the affinity of phenethylamine hallucinogens at the 5-HT2A receptor. N-benzyl substituted derivatives of 2,5-dimethoxy-4-iodophenethylamine (2C-I), such as N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) and N-(2,3-methylenedioxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBMD), have appeared recently as designer drugs, but have not been characterized behaviorally. The head twitch response (HTR) is induced by 5-HT2A receptor activation in rats and mice, and is widely used as a behavioral proxy for hallucinogen effects in humans. Nevertheless, it is not clear whether phenethylamine hallucinogens reliably provoke this behavior. Hence, we investigated whether 2C-I, 25I-NBOMe and 25I-NBMD induce head twitches in C57BL/6J mice. The HTR was assessed using a head-mounted magnet and a magnetometer coil. 2C-I (1-10 mg/kg SC), 25I-NBOMe (0.1-1 mg/kg SC), and 25I-NBMD (1-10 mg/kg SC) induced the HTR. 25I-NBOMe displayed 14-fold higher potency than 2C-I, and the selective 5-HT2A antagonist M100,907 completely blocked the HTR induced by all three compounds. These findings show that phenethylamine hallucinogens induce the HTR by activating 5-HT2A receptors. Our results demonstrate that 25I-NBOMe is a highly potent derivative of 2C-I, confirming previous in vitro findings that N-benzyl substitution increases 5-HT2A affinity. Given the high potency and ease of synthesis of N-benzylphenethylamines, it is likely that the recreational use of these hallucinogens will become more widespread in the future. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 45 条
[1]   Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors [J].
Acuña-Castillo, C ;
Villalobos, C ;
Moya, PR ;
Sáez, P ;
Cassels, BK ;
Huidobro-Toro, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (04) :510-519
[2]   FACILITATION OF 8-OHDPAT-INDUCED FOREPAW TREADING OF RATS BY THE 5-HT2 AGONIST DOI [J].
ARNT, J ;
HYTTEL, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 161 (01) :45-51
[3]   A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis [J].
Benneyworth, Michael A. ;
Xiang, Zixiu ;
Smith, Randy L. ;
Garcia, Efrain E. ;
Conn, P. Jeffrey ;
Sanders-Bush, Elaine .
MOLECULAR PHARMACOLOGY, 2007, 72 (02) :477-484
[4]   Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists [J].
Braden, Michael R. ;
Parrish, Jason C. ;
Naylor, John C. ;
Nichols, David E. .
MOLECULAR PHARMACOLOGY, 2006, 70 (06) :1956-1964
[5]   Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model [J].
Canal, Clint E. ;
Morgan, Drake .
DRUG TESTING AND ANALYSIS, 2012, 4 (7-8) :556-576
[6]   The selective serotonin2A receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats [J].
Dekeyne, A ;
Iob, L ;
Hautefaye, P ;
Millan, MJ .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (04) :552-556
[7]   Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175:: a pharmacological analysis [J].
Dekeyne, A ;
Girardon, S ;
Millan, MJ .
NEUROPHARMACOLOGY, 1999, 38 (03) :415-423
[8]   Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice [J].
Egashira, Nobuaki ;
Shirakawa, Atsunori ;
Okuno, Ryoko ;
Mishima, Kenichi ;
Iwasaki, Katsunori ;
Oishi, Ryozo ;
Fujiwara, Michihiro .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (01) :52-58
[9]  
Erowid, 2013, 251 NBOME 2C 1 NBOME
[10]   Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36 [J].
Ettrup, Anders ;
Holm, Soren ;
Hansen, Martin ;
Wasim, Muhammad ;
Santini, Martin Andreas ;
Palner, Mikael ;
Madsen, Jacob ;
Svarer, Claus ;
Kristensen, Jesper Langgaard ;
Knudsen, Gitte Moos .
MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (04) :376-383